logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Eternal Success Holdings Hong Kong (06812.HK): Hong Minghua resigns as executive director.

date
21/08/2025
Wisdom Financial News APP reported that Mr. Hong Minghua has resigned from his position as executive director of Wing Shun Holdings Hong Kong (06812.HK) after the end of the shareholders' annual meeting.
Latest
1 m ago
Miniso opened higher and is now up more than 9%. Its financial report shows that revenue in the second quarter increased by 23.1% year-on-year, and revenue in the first half of the year increased by 21.1% year-on-year.
2 m ago
Blackstone increases investment in electrification sector: acquires electrical equipment service provider Shermco for 1.6 billion US dollars.
2 m ago
Li Ning (02331.HK) reported a 3.3% year-on-year increase in revenue to 14.817 billion yuan and a net profit of 1.737 billion yuan in the first half of the year.
2 m ago
Some hot Chinese concept stocks surged at the opening of trading, with Miniso rising more than 9%, Xpeng Motors rising more than 7%, BOSS Zhipin and Nio rising more than 5%, and Manbang rising more than 3%.
2 m ago
Dynavax's herpes zoster vaccine phase I/II trial results are comparable to GlaxoSmithKline's Shingrix vaccine.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.